stoxline Quote Chart Rank Option Currency Glossary
  
InfuSystem Holdings, Inc. (INFU)
6.95  0.04 (0.58%)    07-23 16:00
Open: 6.87
High: 6.95
Volume: 163,072
  
Pre. Close: 6.91
Low: 6.851
Market Cap: 148(M)
Technical analysis
2024-07-23 4:53:03 PM
Short term     
Mid term     
Targets 6-month :  8.29 1-year :  9.68
Resists First :  7.09 Second :  8.29
Pivot price 6.71
Supports First :  6.57 Second :  6.25
MAs MA(5) :  6.84 MA(20) :  6.74
MA(100) :  7.61 MA(250) :  8.98
MACD MACD :  0 Signal :  -0.1
%K %D K(14,3) :  79.6 D(3) :  69.3
RSI RSI(14): 55.3
52-week High :  11.43 Low :  6.25
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ INFU ] has closed below upper band by 21.8%. Bollinger Bands are 21.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 6.96 - 6.99 6.99 - 7.02
Low: 6.78 - 6.81 6.81 - 6.84
Close: 6.9 - 6.95 6.95 - 7.01
Company Description

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Headline News

Thu, 18 Jul 2024
InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) Short Interest Update - Defense World

Wed, 17 Jul 2024
Why Is Minerva Advisors Bullish on InfuSystem Holdings, Inc. (INFU) Right Now? - Insider Monkey

Wed, 17 Jul 2024
10 Best Small-Cap Stocks to Buy Now According to Minerva Advisors - Insider Monkey

Mon, 13 May 2024
InfuSystem Holdings, Inc. (AMEX:INFU) Q1 2024 Earnings Call Transcript - Yahoo Finance

Fri, 08 Mar 2024
InfuSystem to Report Fourth Quarter and Full Year 2023 Financial Results on March 14, 2024 - Business Wire

Tue, 14 Jun 2022
InfuSystem and Ventis Pharma Announce National Sales and Marketing Agreement for Pain Management - Business Wire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
AMEX
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 21 (M)
Shares Float 17 (M)
Held by Insiders 5.4 (%)
Held by Institutions 83.3 (%)
Shares Short 239 (K)
Shares Short P.Month 314 (K)
Stock Financials
EPS 0.05
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.43
Profit Margin 0.7 %
Operating Margin 5.2 %
Return on Assets (ttm) 2.4 %
Return on Equity (ttm) 1.8 %
Qtrly Rev. Growth 17.2 %
Gross Profit (p.s.) 2.94
Sales Per Share 5.79
EBITDA (p.s.) 0.76
Qtrly Earnings Growth 50 %
Operating Cash Flow 11 (M)
Levered Free Cash Flow -2 (M)
Stock Valuations
PE Ratio 139
PEG Ratio 13
Price to Book value 2.86
Price to Sales 1.19
Price to Cash Flow 13.22
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android